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Section I: Abstract 
Problem: The potential harm to women and infants due to untreated perinatal anxiety and mood 
disorders is both a patient safety and a public health concern. Studies show that mental health 
decline during the postpartum period is associated with increased morbidity and mortality for 
both the mother and infant. The project aim was to utilize the initial screening of perinatal 
patients using the Columbia-Suicide Severity Rating Scale (C-SSRS) as the baseline screening 
tool. The tool will help implement a standardized workflow for patients who screen low, 
moderate, or high, as this workflow had yet to be developed. 
Context: In July 2019, the Joint Commission released new elements to their National Patient 
Safety Goal 15.01.01: Reduce the risk for suicide, which required suicide screening for all 
admitted patients. In August 2020, the hospital in this study screened all patients with the C-
SSRS on admission. Even when hospitals screen patients for suicide or other mental health 
disturbances, a nationally accepted standard workflow for positive screens does not exist. This 
improvement project focused on creating a standardized workflow for perinatal patients who 
screened positive on the C-SSRS by implementing an inpatient clinical pathway. 
Interventions: The primary intervention for this project was to create the inpatient clinical 
pathway for perinatal patients who screen positive on the C-SSRS. The initial step in the 
pathway was to ensure all positive patients had a social work consult, and those who scored 
moderate or severe also had an inpatient psychiatry referral. The secondary intervention was to 
ensure all patients received the Mind-Body-Spirit flyer containing outpatient resources for 
continued support when they are home. 
Measures: To measure the success of the C-SSRS pathway, the team tracked all perinatal 
patients who screened positive on the C-SSRS. The outcome measure tracked the percentage of 
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patients who screened positive on the C-SSRS and had the interventions completed. The first 
process measure followed all positive C-SSRS patients against the number of social work 
consults placed and seen before discharge. The second measure tracked all patients who screened 
moderate or high, the psychiatry consult was initiated, and the patient was seen before discharge. 
The third process measure was the percent of postpartum nurses trained to use the C-SSRS 
clinical pathway. The incidence rate of inappropriate referrals to social work and psychiatry was 
used as the balancing measure. 
Results: Of the perinatal patients who screened positive (low, moderate, high) on the C-SSRS, 
100% had a social work referral and were seen before discharge. Of the patients who screened 
moderate or high, 100% had an inpatient psychiatry referral and were seen before discharge. The 
safety plan was not initiated on the one patient who screened high, as she was in active labor and 
the psychiatrist determined she was not actively suicidal. Education on the C-SSRS pathway was 
successful, with 95% of postpartum nurses receiving the instruction.  
Conclusions: This project aimed to develop an inpatient clinical pathway to be used with 90% of 
perinatal patients who screened positive (low, moderate, high risk) on the C-SSRS. The hospital 
in this study was able to implement the C-SSRS pathway on the postpartum unit successfully.  
Keywords: Columbia-Suicide Severity Rating Scale (C-SSRS), perinatal mental health, 
postpartum, screening tools 
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Section II: Introduction 
Over 600,000 infants are born in the United States every year to mothers who suffer from 
perinatal depression (Postpartum Support International [PSI], 2021; Smith, 2012). Perinatal 
mental health concerns are gaining attention at national, regional, and local levels. With the 
added stress of the COVID-19 pandemic, mental health disparities have been recognized and 
have shed light on this often-overlooked patient population. According to Choi et al. (2020),  
Clinicians and experts are raising concerns about the pandemic’s potential to cause far-
reaching harm to the mental health of women and infants. During the pandemic, women 
are at increased risk for depression, anxiety, post-traumatic stress disorder, and suicidality 
precipitated by new pandemic-related stressors. (p. 410)  
There are many missed opportunities to screen recently delivered mothers. When women 
are not screened for mood disorders and left untreated, severe clinical depression may develop 
for some women (Dennis & Doswell, 2013). In fact, “Perinatal mood and anxiety disorders are 
associated with increased risks of maternal and infant mortality and morbidity and are 
recognized as a significant patient safety issue” (Kendig et al., 2017, p. 272). Orsolini et al. 
(2016) noted, “Perinatal suicidality, which comprises completed suicides, suicide attempts, 
suicidal ideation, and thoughts of self-harm, is nowadays considered one of the leading causes of 
maternal mortality in the first 12 months postpartum” (p. 2). 
The Columbia-Suicide Severity Rating Scale (C-SSRS) is a validated screening tool used 
to assess suicide risk (Columbia Lighthouse Project, 2016; see Appendix A). It is used by first 
response agencies, healthcare facilities, military installations, colleges and schools, and 
correctional facilities This risk assessment tool was created to be a simple, easy-to-read and 
understand instrument using questions that anyone, including non-professional people, could use 
7 
to determine if someone has suicidal thoughts. The C-SSRS is considered universal, as it has 
been translated into over 100 languages and is suitable for use with any age group (Columbia 
Lighthouse Project, 2016). Using the C-SSRS on admission could assist the healthcare team in 
identifying at-risk perinatal patients, allowing for the implementation of patient-centered 
interventions and resources.  
Prior to the COVID-19 pandemic, the World Health Organization projected that by 2020, 
depression would carry the highest disease burden of all health conditions in women (Dennis & 
Doswell, 2013). It is also suspected that 50% of women with perinatal mood and anxiety 
disorders (PMADs) are not identified (Accortt & Wong, 2017). When screening is implemented, 
there is still a gap in coordinating and providing interventions (PSI, 2021). PMAD interventions 
need to be created and inpatient clinical pathways solidified. Gaps in patient discharge planning 
and resources have long been identified (Sullivan Group, 2021). Implementing patient and 
family anticipatory teaching and resources should be standardized and dispersed to all applicable 
patients and their support persons.    
Problem Description 
Most hospital systems in the United States have not routinely used validated tools to 
screen pregnant and recently postpartum women (Long et al., 2019). When hospitals initiate 
screening for depression, mood disorders, or suicidal ideation, there is a lack of patient-centered 
interventions and resources. The hospital microsystem in this change in practice project 
integrates the Patient Health Questionnaire (PHQ-9) screening tool in prenatal appointments and 
routine pediatric appointments. Screening occurs at least twice during pregnancy and at well-
baby appointments. The American Congress of Obstetricians and Gynecologists recommends 
screening with a validated tool for anxiety and depression symptoms at least once in pregnancy 
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and postpartum (Accortt & Wong, 2017). The American Academy of Pediatrics recommends 
screening mothers at every well-baby visit (Accortt & Wong, 2017). Even with double the 
screening rate in this hospital, the postpartum microsystem still lacks an inpatient PMAD 
pathway for perinatal patients.   
In July 2019, the Joint Commission (2021) released new elements to their National 
Patient Safety Goal (NPSG) 15.01.01: Reduce the risk for suicide, which required suicide 
screening for all admitted patients. As a result of the revised NPSG, the hospital in this study 
began screening patients with the C-SSRS in August 2020. From August 2020 through February 
2021, data showed that 96% of patients were screened with the C-SSRS within 8 hours of 
admission. The postpartum unit, also known as the mother-baby microsystem, did not have a 
straightforward clinical pathway for positively screened patients.   
In August 2019, the regional offices of the hospital system created a perinatal mental 
health (PMH) group to improve the mental health of pregnant and newly postpartum patients and 
formed a multi-professional and multi-medical center collaborative community of practice. The 
initial goal was to formulate a patient-centered local resource list that would be provided during 
discharge teaching. In July 2021, the revision of an established regional patient handout, titled 
the Mind-Body-Sprit flyer, was completed as one of the interventions implemented during the 
project (see Appendix B). The initial regional patient handout had some inaccurate phone 
numbers and was missing other local resources; thus, the team needed to revise before initial 
distribution. Once finalized, the flyer required a way for distribution, so that all patients would 
receive it and be educated on the contents.  
Growing the local PMH team and using the interdisciplinary members for improvement 
projects was one way to improve communication and unite the team. The original project aim 
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was to decrease untreated PMAD symptoms in the patient, the newborn baby, and the entire 
family unit. After a gap analysis, it was found that before working on PMAD interventions, there 
was a need to improve upon a pre-established C-SSRS clinical pathway to identify those at risk 




In postpartum women (P), how does using a screening tool to identify at-risk moms for 
postpartum mental disturbances (I), compared to those without the use of a screening tool (C), 
affect mood or psychiatric disturbance identification and treatment (O) within one year 
postpartum (T). 
Multiple literature reviews were conducted throughout the planning and implementation 
phase of the project. Topics searched included screening and implementing interventions for 
perinatal mood disorders. The initial literature review conducted in February 2020 was followed 
up with ongoing research completed in July 2021. The evidence was reviewed using the 
following databases: Cochrane Database of Systematic Reviews, CINAHL Complete, Pub Med, 
MEDLINE, and AHRQ evidence reports. Keywords searched included postpartum, mental 
illness, psychiatric disorders, mood disorders, reducing maternal symptoms, and screening tools. 
Limitations were set to include English language, peer-reviewed research, and publication dates 
of 2015 to 2021. The Cochrane review was published in 2013 and was included due to the 
thoroughness of the study. Ten articles were retrieved with clinical significance to the PICOT 




The Johns Hopkins Nursing Evidence-Based Practice research and non-research evidence 
appraisal tools were selected to review the evidence (Dang & Dearholt, 2018). Three Level I A 
articles, one Level II B, one Level III B, one Level IV B, one Level V A, and one Level V B 
were selected to broaden the understanding of the problem and included in the evidence-based 
research table (see Appendix C).  
The Cochrane review (Level I A) included 28 randomized controlled trials using both 
primary meta-analysis and fixed-effect meta-analysis to combine the study data with a sample 
size of 17,000 pregnant or newly postpartum women (Dennis & Doswell, 2013). This study 
showed that women who received a psychosocial or psychological intervention were 
significantly less likely to develop postpartum depression than those receiving standard care, 
with an average RR 0.78 and 95% confidence interval. The top three identified interventions 
were individualized postpartum home visits, peer-based telephone support, and interpersonal 
psychotherapy (Dennis & Doswell, 2013). 
The next Level I A study by Long et al. (2019) included 25 systematic reviews and meta-
analysis studies. This study revealed that screening for perinatal mood disorders is inconsistent 
and low among healthcare providers in the United States. Long et al. indicated that not only does 
screening need to be implemented, but referrals are needed as well.  
Song et al. (2015) looked at 14 randomized control trials in a systematic review, and 13 
of those studies were included in a meta-analysis (Level I A). Their results showed that the use 
of psychosocial interventions, such as stress management, proved to be an effective treatment for 
reducing symptoms of depression.  
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McCarter-Spaulding and Shea (2015) completed a quasi-experimental study including 
240 women (rating Level II B), showing that educating women about postpartum depression 
symptoms while in the hospital did not decrease their symptoms.  
Albaugh et al. (2018), in a retrospective descriptive study of 647 women (Level III B), 
provided information that only half of the women referred for mental health during their 
postpartum period attended their appointment.  
Choi et al. (2020) provided practice guidelines and recommendations (Level IV B), 
pulling information from 17 organizations to address the COVID-19 pandemic and increasing 
concerns for mental health disturbances to rise.  
A literature review by Accortt and Wong (2017) revealed that 19.2% of postpartum 
women experience depressive symptoms in the first 3 months postpartum (Level V B); therefore, 
routine screening with validated tools is necessary. They also identified that depression and 
anxiety rates are higher for women who experience an adverse perinatal complication or 
outcome, such as a baby in the neonatal intensive care unit (NICU), preterm birth, or maternal 
preeclampsia. 
The final article chosen for review was a literature review and practice standards, 
including four studies (Level V B). Potter (2017) looked at universal screening for mood 
disorders for childbearing women and implications for practice. The researcher noted, “Ensuring 
universal screening and accurate diagnosis is just the first step; culturally competent, 
comprehensive, and effective treatment options must be available to all women” (Potter, 2017, p. 
459).   
Synthesizing the evidence revealed that the foundational perinatal mental health problem 
lacks consistent screening for mood disorders in this patient population. Even though many 
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organizations have established clinical guidelines, not all healthcare systems consistently use 
validated screening tools during the perinatal periods. After reviewing the PICOT question and 
evidence, it was determined that the hospital and microsystem in this improvement project was 
already consistently using these validated tools. Initially, the project focused on creating an 
inpatient PMAD clinical pathway with referrals, treatment options, and easily accessible 
resources. The PMAD pathway was too broad, so the PMH team decided to begin by creating the 
C-SSRS clinical pathway (see Appendix D). Those patients with self-harm thoughts are a 
smaller, more targeted group. Research has shown that the prevalence of suicidal ideation during 
the perinatal period ranges from 5% to 14% (Orsolini et al., 2016). Starting with a smaller patient 
population gave the team a tangible improvement project. 
Rationale 
Neuman (2017) systems model and McGonigal’s (2017) 4C change model constituted the 
project’s conceptual and systems model frameworks. Partnered together, the two models helped 
guide the evidenced-based practice change of initiating a clinical pathway for interventions and 
resources for at-risk moms. 
Neuman (2017) systems model is a unique, open, systems-based perspective that focuses 
on wellness and the person as a whole and guides the nurse to see their client (the preferred term) 
in a holistic view. The sole purpose is not just for the individual, but also for groups, 
communities, organizations, and families. Betty Neuman developed her systems model in 1970 
as a conceptual framework to help guide her students’ learning at the University of California 
Los Angeles. Since 1970, the Neuman systems model has continued to evolve and has become 
one of the top conceptual models used by nursing. Neuman’s model “focuses attention on the 
response of the client system to actual or potential environmental stressors, and the use of 
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primary, secondary, and tertiary nursing prevention interventions for retention, attainment, and 
maintenance of optimal client system wellness” (Neuman, 1996, p. 67). This resiliency 
encompasses physiological, psychological, sociocultural, developmental, and spiritual variables 
simultaneously, where optimal health encompasses total health attainable at one moment in time 
(Neuman, 2017).  
Kotter’s well-respected change model was used as the foundation of the 4C model 
(McGonigal, 2017). This model can be the framework to tackle any evidence-based 
improvement project, from simple to complex. The first step in the model is to center, or create a 
clear focus, on the issue at hand. The second step is collaboration, or bringing the team together 
using straightforward communication tools. The third step of change uses tools, such as plan-do-
study-act (PDSA), to make the change. The fourth and final step is to celebrate success. This 
model has been successful in other change initiatives in the postpartum unit of focus. 
Specific Project Aim 
This project aims to develop an inpatient clinical pathway to be used with 90% of 
perinatal patients who screen positive (low, moderate, high risk) on the C-SSRS by July 2021. 
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Section III: Methods 
Context 
The focus of the population is from the postpartum unit in a large medical center in 
Northern California with 60 licensed postpartum beds and an average monthly delivery volume 
of 550 babies. The Institute for Healthcare Improvement’s (IHI) microsystem assessment tool 
and the Dartmouth Institute’s microsystem assessment tool (IHI, 2003) were used to assess this 
microsystem in February 2021. The multidisciplinary team includes a nurse manager, 12 
assistant nurse managers, 200 obstetrical doctors and midwives, six pediatricians, five licensed 
clinical social workers, and 130 staff nurses. The assessment identified that multidisciplinary 
work was needed surrounding perinatal mental health.   
The hospital unit had good foundational work, beginning with screening using the C-
SSRS with every admission since August 2020 (Columbia Lighthouse Project, 2016). In addition 
to the C-SSRS, abuse, AUDIT (alcohol use disorders identification test), mutuality/individual 
preferences, and mental health review of symptoms questions are all asked upon admission to 
labor and delivery. These tools are all validated for screening purposes, but no guidelines were in 
place for follow-up when patients screen positive.   
SWOT Analysis 
The PMH team conducted a SWOT (strengths, weaknesses, opportunities, and threats) 
analysis, showing that the strengths of this work outweigh the threats (see Appendix E). The 
project’s strengths were that the C-SSRS screening was a standard of practice, and social work 
referrals were already being placed for many patients with PMAD symptoms. Other potential 
strengths of the project were increasing communication and awareness of PMAD symptoms and 
improving patient outcomes. The potential weaknesses included staff resistance to change and 
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patients not being ready for intervention. Other potential weaknesses and threats could involve 
the impact on outpatient resources, with delays in outpatient appointments due to availability. 
Opportunities for this project could consist of spreading discovered best practices to other 
postpartum units, decreasing the stigma of PMAD, and identifying individuals with thoughts of 
self-harm. Early identification and intervention lead to better patient outcomes. 
Cost-Benefit Analysis 
The PMH team also completed a cost/benefit analysis (see Appendix F). The preliminary 
budget for the startup and continuation of the C-SSRS pathway is associated with employee 
salary and printing the Mind-Body-Spirit flyer. Utilizing established staff would mitigate any 
cost increase. Using an established 5-minute huddle message at the start of the shift by the 
assistant nurse manager and during the monthly staff meetings was the education method used. 
Nominal costs associated with the general use of resources could also be captured in the routine 
unit budget. The only additional procurement of resources necessary for the C-SSRS clinical 
pathway to succeed is printing the Mind-Body-Spirit flyer. The annual cost for this flyer at this 
medical center is $1,553.64. Patients placed on the C-SSRS clinical pathway could decrease 
long-term outpatient budgets. A report published by Mathematica estimated that untreated 
perinatal mental health disorders cost the United States $14.2 billion in 2017 (PSI, 2021). 
Decreasing the risk of a mood disorder from turning into severe clinical depression and 
then self-harm could reduce outpatient and later inpatient mental health needs. According to 
Accortt and Wong (2017), “Depression increases health care costs and decreases productivity of 
women affected, as well as the well-being of their offspring” (p. 559). 
Intervention 
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 Focused interventions facilitate decreasing the adverse effects that PMADs can have on a 
patient and their family. These interventions begin upon admission by screening all patients with 
the C-SSRS. The primary intervention is triggering the social work and psychiatry consults, 
when indicated. Secondary preventative approaches, such as social support, stress reduction 
techniques, psychological therapies, cognitive behavioral therapy, or when indicated, 
pharmacological treatments (Accortt & Wong, 2017), will be added in later. The final 
intervention is educating all postpartum nurses on using the new pathway. 
Study of the Intervention 
Measurement is key to the implementation success of any quality improvement project. 
The PMH team used several PDSA cycles looking for the best interventions for their 
microsystem. Evaluation of the C-SSRS pathway occurred daily with internal audits of Health 
Connect, the secure communication network, or the inpatient record. The auditor used the 
Suicide Risk Harvey Ball on the patient list to quickly assess all perinatal patient charts to 
determine if they had been screened with the C-SSRS tool on admission. Next, the auditor 
verified that those who screened positive had a social work referral and those who screened 
moderate or high also had a psychiatry referral. There was planned auditing for distribution of 
the Mind-Body-Spirit resource handout; however, the revised handout was not available until 
after the initial project implementation. According to McCarter-Spaulding and Shea (2015), 
“Limited nursing time during hospitalization may be better spent on implementing a mechanism 
for ensuring adequate follow-up after discharge for women at risk” (p. s59); therefore, future 
PDSA cycles will revolve around utilizing resources after discharge. 
When the inpatient C-SSRS clinical pathway was created, many PDSA cycles were 
performed to help determine the next steps. The Mind-Body-Spirit resource list was updated by 
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the PMH team, and after the implementation period, the team trialed ways to make the 
distribution meaningful. These were rapid-fire cycles based on the nurses’ verbal input. Initially, 
they trialed having the flyer handed to the patient on admission; next, they trialed giving it to the 
patient with the discharge instructions. The preliminary results showed that for sustainability, the 
flyer should be placed in the admission packet, so that the admission and discharge nurses could 
go over it with the patient and support persons. Having the flyer at the bedside on admission 
made it easy for the nurse to pull it out and share it with the patient. Expecting that both the 
admission and discharge nurse would go over the flyer increased the discussion rate and ensured 
distribution to 100% of patients.  
The group also conducted two PDSA cycles on downloading and using the Calm 
application (app) with patients (see Appendix G). In the first 2-week trial, the selected 
postpartum nurses assisted their patients with downloading the Calm app. The second 1-week 
trial included asking the patient to use the app at least once during their hospitalization. The 
Calm app is a stress management/relaxation tool that could assist in reducing symptoms of 
depression. This app was vetted by the hospital system and is offered free for a year to members. 
The Calm app PDSAs are still in progress, with favorable preliminary results. The Calm app 
PDSA cycles had to be temporarily put on hold during the implementation period, as the free 
link was temporarily disabled. The link was enabled after a short time, and the team has plans to 
continue working on PDSAs using it. 
Future PDSA cycles will involve the discharge nurse assisting the patient in signing up 
for a class or support group before discharge. The group looked at other PMAD interventions, 
such as instituting talking therapy utilizing the primary nurse or obstetric rounder to ask the 
patient how their delivery went, and then listen to their perspective of the delivery experience. If 
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the conversation raised concerns that the patient had unresolved questions about the birth, they 
would call the nurse midwife (or another provider) and ask for a debrief. As this was subjective 
data, the group decided to hold off on the talk therapy and debrief PDSAs until after completing 
the C-SSRS project. In addition, the PMH team determined that the PDSA cycle of discharge 
calls, asking the patient about the Calm app and the Mind-Body-Spirit flyer, was currently 
unsustainable. 
Measures 
Four measures were created to assess the proper implementation of the C-SSRS pathway: 
three process measures, an outcome measure, and a balancing measure. An initial project charter 
was created in February 2021 surrounding perinatal mental health needs (see Appendix H) and 
was later updated to the narrower focus of the C-SSRS implementation. The outcome measure 
included the successful implementation of the C-SSRS pathway. To be considered successful, 
the team had to ensure that 90% of patients who screen positive (low, moderate, high risk) on the 
C-SSRS would have a social work referral placed, and 100% of those patients who screen 
moderate or high would have an inpatient psychiatry order placed and a safety plan initiated 
when high. 
The first process measure was a social work referral triggered upon admission by a 
perinatal patient who screened low, moderate, or high on the C-SSRS. The future goal of the 
complete PMAD pathway will also include patients who screen positive on the abuse, AUDIT, 
mental health review of symptoms, and the outpatient PHQ-9 score of 10 or higher and patients 
with a traumatic delivery requiring a debrief, NICU admission, or fetal demise. The second 
process measure tracked all patients who screened moderate or high on the C-SSRS and had 
inpatient psychiatry referrals and visits before discharge. The third process measure was the 
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percent of postpartum nurses trained to initiate the C-SSRS clinical pathway, with a goal of 90% 
of nurses educated. The balancing measure was the incidence rate of inappropriate referrals to 
inpatient social work and psychiatry. The goal was not to miss any at-risk patients while using 
the resources already available. 
Ethical Considerations      
 Enhancing maternal mental health is fundamental for decreasing clinical depression, thus 
reducing the burden of disease. According to Dennis and Doswell (2013), “There is a substantial 
body of evidence showing that maternal depression and subsequent poor maternal-infant 
interactions adversely affect the developing child” (p. 4). A project focused on improved mental 
health for perinatal patients and improved maternal and child health is ethically sound. The C-
SSRS pathway will increase the postpartum nurses’ knowledge, skill, and attitudes surrounding 
perinatal mental health. Decreasing PMAD stigma will engage the frontline nurses and increase 
their job satisfaction. 
 This project aligns with the American Nurses Association’s (ANA) nine provisions of the 
Code of Ethics for Nurses. Provision 1 states, “The nurse practices with compassion and respect 
for the inherent dignity, worth, and unique attributes of every person” (ANA, 2015, para. 1). 
Provision 3 states, “The nurse promotes, advocates for, and protects the rights, health, and safety 
of the patient” (ANA, 2015, para. 3). Creating a safe environment for the patient, including 
identifying one’s suicide risk and other PMAD indicators, follows these provisions.  
 After review from the University of San Francisco faculty, this project was determined to 
qualify as an evidence-based change in practice project rather than a research project. When a 
project is a change in practice and not research, Institutional Review Board approval is not 
required. A statement of determination as a non-research project was approved (see Appendix I).
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Section IV: Results 
Outcome Measure Results 
Preliminary data revealed that the PMH team was successful in the implementation of the 
C-SSRS pathway. Prior to implementation, only 50% of patients with a positive screen (low, 
moderate, high) on the C-SSRS had the correct interventions of social work and/or psychiatry 
referrals placed and seen before discharge. After implementation, 100% of patients who screened 
moderate and high had an inpatient social work and psychiatry order placed and were seen 
before discharge (see Appendix J). One patient screened high post-implementation, but was in 
active labor and cleared by the psychiatrist, so the additional safety plan was not initiated. There 
were no patients who scored low on the C-SSRS during the implementation period of June and 
July 2021. Ninety-five percent of postpartum nurses, subtracting those on a medical leave during 
implementation, were educated on the C-SSRS pathway during the huddle message and staff 
meetings.  
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Section V: Discussion 
Summary 
The PMH team successfully implemented the C-SSRS clinical pathway in June of 2021 
on the postpartum unit. There were many lessons learned during the implementation period. The 
first lesson learned was that it is crucial to break down a project into smaller, more tangible 
pieces when initiating a change of such breadth. The evidence revealed that the hospital was 
already screening 96% of their patients with the C-SSRS, but needed improvement with 
referrals, treatment options, and resources. This improved workflow proved to be the foundation 
required before moving other perinatal mood disorder work forward.  
Pulling together a multidisciplinary team to form a PMH group proved to be the first 
challenge encountered. With implementing a change in practice in such a busy postpartum 
department, there are many competing priorities. Key stakeholders needed to be included and 
kept informed of the work. Before the project initiation, there were no providers who wanted to 
head up the PMH group. The clinical nurse leader student was already an established leader on 
the unit as an assistant nurse manager for over 10 years. Using her influence, experience, and 
knowledge of the providers’ passions, she secured an OB/GYN physician and a certified nurse 
midwife for the team. Still, completing this group did take more time than anticipated. Once the 
group formed, there was buy-in from like-minded, passionate individuals. Even when not all 
team members could attend the meetings, email and one-on-one interactions moved the work 
forward.   
Conclusion 
The decline in perinatal mental health acute and long-term effects is an urgent public 
health issue in the United States (PSI, 2021). All postpartum microsystems could benefit from 
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streamlining the inpatient pathway for PMADs, beginning with screening using the C-SSRS, to 
improve the mental health of this patient population. Kendig et al. (2017) reported, 
When left untreated, perinatal mood and anxiety disorders can have profound adverse 
effects on women and their children, ranging from increased risk of poor adherence to 
medical care, exacerbation of medical conditions, loss of interpersonal and financial 
resources, smoking and substance use, suicide, and infanticide. Perinatal mood and 
anxiety disorders are associated with increased maternal and infant mortality and 
morbidity risks and are recognized as a significant patient safety issue. (p. 272) 
Patient safety concerning mortality and morbidity is one implication for sustained 
practice improvement. In 2020, the hospital system in focus put out a Health Stream, an online 
educational training module, educating all frontline nursing staff on the new NPSG to reduce the 
risk for suicide and the corresponding implementation of the C-SSRS as their screening mode. 
Even with this education, many labor and delivery and postpartum staff members did not see this 
goal as a priority for their patient population. With a lengthy module not tailored to their needs, 
and due to the added stress of the COVID-19 pandemic, it did not get initiated in a viable way in 
2020. 
Improving PMAD and C-SSRS screening and using easy-to-follow inpatient clinical 
pathways that include referrals, treatment options, and easily accessible outpatient resources for 
discharge are simple ways to help this vulnerable population. When you make simple workflow 
changes easy to follow, they have built-in sustainability. Decreasing the risk of exacerbating 
PMAD symptoms, such as self-harm, by supporting families through early screening, treatment 
and resources supports and builds a healthy family dynamic. 
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Appendix A. Columbia-Suicide Severity Rating Scale 
Please place a check mark in the box for the appropriate answers 
Please answer question 1 and 2 
Ask Questions 1 and 2   
1) Have you wished you were dead or wished you could go to sleep and not 
wake up?  
2) Have you actually had any thoughts of killing yourself? 
If YES to 2, ask questions 3, 4, 5, and 6.  If NO to 2, go directly to question 6. 
3) Have you been thinking about how you might do this? 
e.g. “I thought about taking an overdose but I never made a specific plan as to 
when where or how I would actually do it….and I would never go through with it.”  
4) Have you had these thoughts and had some intention of acting on them? 
as opposed to “I have the thoughts but I definitely will not do anything about 
them.”  
5) Have you started to work out or worked out the details of how to kill 
yourself? Do you intend to carry out this plan?  
6) Have you ever done anything, started to do anything, or prepared to do 
anything to end your life? 
Examples: Collected pills, obtained a gun, gave away valuables, wrote a will or suicide note, 
took out pills but didn’t swallow any, held a gun but changed your mind or it was grabbed 
from your hand, went to the roof but didn’t jump; or actually took pills, tried to shoot 
yourself, cut yourself, tried to hang yourself, etc. 
 
If YES, ask: Was this within the past 3 months?  
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Appendix C. Evaluation Table 
 
PICOT Question: In postpartum women (P), how does using a screening tool to identify at-risk moms for postpartum mental 
disturbances (I), compared to those without the use of a screening tool (C), affect mood or psychiatric disturbance identification and 
treatment (O) within 1 year postpartum (T). 
 
Study Design Sample Outcome/Feasibility 
Evidence 
Rating 
Accortt, E. E., & Wong, M. S. (2017). 
It is time for routine screening for 
perinatal mood and anxiety disorders in 
obstetrics and gynecology settings. 




Literature review   4,700 patients Data revealed that 19.2% of 
postpartum women experience 
depressive symptoms in the first 3 
months postpartum. 
 
Helpful in providing the 9 PHQ as 
a tool for assessment before 
discharge (after delivery). 
V A 
Albaugh, A. S., Friedman, S. H., & 
Rosenthal, M. (2018). Attendance at 
mental health appointments by women 
who were referred during pregnancy or 
the postpartum period. Journal of 
Obstetric, Gynecologic & Neonatal 





647 women  Only half of the women referred 
for mental health during their 
postpartum period attended. 
 




Study Design Sample Outcome/Feasibility 
Evidence 
Rating 
Choi, K. R., Records, K., Low, L. K., 
Alhusen, J. L., Kenner, C., Bloch, J. R., 
Premji, S. S., Hannan, J., Anderson, C. 
M., Yeo, S., & Logsdon, M. C. (2020). 
Promotion of maternal-infant mental 
health and trauma-informed care 
during the COVID-19 pandemic. 
Journal of Obstetric, Gynecologic & 








Guidelines for maternal health 
during a pandemic, covering 
inpatient postpartum 
considerations.   
 
Useful for current pandemic 
situation (raising concerns for 
increased risk for mental health 
disturbances). 
IV B 
Dennis, C. L., & Doswell, T. (2013, 
February 28). Psychosocial and 
psychological interventions for 
preventing postpartum depression. 















Early identification of at-risk 
mothers contributed to decreased 
levels of postpartum depression.  
 
Guides the CNL in proposing 
interventions, including resources.  
I A 
Long, M. M., Cramer, R. J., Jenkins, J., 
Bennington, L., & Paulson, J. F. 
(2019). A systemic review of 
interventions for healthcare 
professionals to improve screening and 
referral for perinatal mood and anxiety 
disorders. Archives of Women’s Mental 






25 studies A review of the studies indicates 
that the use of a screening and 
referral system is needed. 
 
It guides the CNL to propose a 
consistent screening tool for 
perinatal mood and anxiety 




Study Design Sample Outcome/Feasibility 
Evidence 
Rating 
McCarter-Spaulding, D., & Shea, S. 
(2015). Effectiveness of postpartum 
education in the reducing symptoms of 
postpartum depression. Journal of 
Obstetric, Gynecologic & Neonatal 





240 women Educating postpartum moms on 
depression symptoms while in the 
hospital did not decrease 
symptoms of postpartum 
depression. 
 
The CNL can use the 
recommendation of spending time 
implementing a pathway for 
follow-up for at-risk moms after 
discharge instead of educating 
moms inpatient. 
II B 
Potter, M. T. (2017). Nurse-led 
initiatives to implement universal 
screening for perinatal emotional 
complications. Nursing for Women’s 






4 studies The use of the Edinburgh Postnatal 
Depression Scale (EPDS) is the 
most common and reliable tool. 
 
The CNL looks at professional 
practice standards and utilizes 
AWHONN, ACOG, and American 
College of Nurse-Midwives 
position statements for screening 
to implement use.  
V B 
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Study Design Sample Outcome/Feasibility 
Evidence 
Rating 
Song, J.-E., Kim, T., & Ahn, J.-A. 
(2015). A systematic review of 
psychosocial interventions for women 
with postpartum stress. Journal of 
Obstetric, Gynecologic & Neonatal 







and meta-analysis  




included in a 
meta-analysis 
The use of psychosocial 
interventions (including stress 
management) proved to be 
effective in reducing symptoms of 
depression. 
 
The CNL should include 
psychosocial programs in the 




















•Early indentification could 
decrease symptoms of PMAD
•Improves patient outcomes
Weaknesses
•Staff could resist change
•Some patients might not be 
ready for interventions
•Potential delay in patient 
being seen by inpatient psych
•Might not have outpatient 
services available within 
resonable time frame
Threats
•Nurses perceived as acting 
outside of their scope of 
practice
•Finding more patients needing 
interventions without enough 
outpatient resources
Opportunities
•Can be spread to other units
•Small size might aid change 
adaption
•Decreasing stigma of PMAD
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Appendix F. Cost-Benefit Analysis 
 
FTE Expense 
160 staff, 5-minute education during the beginning of shift huddle and staff meetings. Clinical 
nurse leader (CNL) student time for the project. PMH team meetings included $86 per hour per 
RN. Other team members are exempt and work the meeting into their regularly scheduled shift. 
Non-FTE Expense 
Mind-Body-Spirit flyer $11.77 per pack of 50 
For 550 (average delivery per month) cost is $129.47 per month or $1,553.64 per year 
The total cost for the first year with FTE and Non-FTE expenses is $4,913.64 
 
FTE Expense Startup Annual Cost Total Cost First Year 
Education during staff 
meeting 
$0 $0 $0 (already in annual 
budget) 
Education during huddle $0 $0 $0 (already in annual 
budget) 
CNL student time $0 $0 $0  
Committee meeting time: 
$86/hour per RN  
3 RNs x 6 startup 
meetings = 
$1,548 





Non-FTE Expense Startup Annual Cost Total Cost First Year 
Mind-Body-Spirit Flyer $129.47/month $1,553.64 $1,553.64 
Calm app $0 - free to KP 
members for the 
first year 
$0 for the first year The annual cost for 
the patient after the 










Calm App Job Aid 
 
Step 1:  Scan barcode with camera 
 
 




  Step 3:  Log into KP.org 
 
 
STEP 4: Download Calm app by selecting “Get”              
 
Step 5:  Enjoy app free for 1 year 
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Appendix H. Project Charter 
Perinatal Columbia-Suicide Severity Rating Scale (C-SSRS) Clinical Pathway Charter 
Project Charter: Inpatient Perinatal C-SSRS clinical pathway project charter. 
Global Aim: To decrease symptoms of perinatal mood and anxiety disorders (PMAD) and 
increase women’s mental health, thus decreasing potential adverse effects on newborn babies 
and families. 
Specific Aim: The aim of this project is to develop an inpatient clinical pathway to be used with 
90% of perinatal patients who screen positive (low, moderate, high risk) on the Columbia-
Suicide Severity Rating Scale (C-SSRS) by July of 2021.   
Background:   
Mental health, in particular perinatal mental health, is gaining attention, as the World Health 
Organization projected that by 2020, depression would carry the highest disease burden of all 
health conditions in women (Dennis & Doswell, 2013). There are many missed opportunities to 
screen inpatient perinatal patients. When patients are not screened for mood disorders or are 
screened and not treated, severe clinical depression can occur for some women (Dennis & 
Doswell, 2013). Accortt and Wong (2017) reported that “PPD (postpartum depression) is the 
most common complication associated with pregnancy and childbirth” (p. 554). It is also 
suspected, by self-reports, that 50% of persons with perinatal mood and anxiety disorders are not 
identified (Accortt & Wong, 2017). Even when screening is implemented, a gap can occur with 
identifying interventions during hospitalization and creating pathways for patients (Potter, 2017). 
These interventions would need to be made, and pathways solidified. Resources for discharge 
need to be identified, consolidated in a way that is easy to understand, and then shared with 
patients.    
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At-risk postpartum patients are those with PMAD, birth trauma, NICU admission, 
posttraumatic stress disorder, and socioeconomic risk factors. Many hospital systems in the 
United States do not consistently use the available validated tools to screen pregnant and recently 
postpartum women, even though the American College of Obstetricians and Gynecologists 
(ACOG) and other public health organizations have widely recommended it (Accortt & Wong, 
2017). Even when hospitals initiate screening for depression or other mood disorders, there is 
still a lack of interventions and resources. The hospital that is the focus of this study integrates 
the Patient Health Questionnaire (PHQ-9) screening tool in prenatal appointments and routine 
newborn, pediatric appointments. While the screening rate is high, there is no standard of 
practice or clinical pathway for inpatient perinatal patients. 
Sponsors 
Chief Nurse Executive DR 
Director of Women’s and Children’s MB 
Chief of Obstetrics and Gynecology 
(OBGYN and CNM Chiefs) 
JC & MB 
 
Goals  
The purpose of this project is to decrease perinatal mood disorders from adversely affecting 
women and babies by: 
1. Using current screening tools to identify at-risk patients consistently. 
2. Creating and implementing a clinical pathway for nurses and providers to follow when a 
postpartum woman is identified as at-risk for perinatal mood disorders, beginning with 
the Columbia-Suicide Severity Rating Score. 




Measure Data Source Target 
Outcome   
C-SSRS workflow utilization Chart review - Health Connect 90% 
Process   
Social work (SW) referral for 
low/moderate/high C-SSRS 
SW referral inbox in Health 
Connect 
90% 
Psychiatry referral for 
moderate and high C-SSRS 
Psychiatry note in Health 
Connect 
100% 
Percent of postpartum nurses 
trained to use C-SSRS 
workflow 
Huddle message and staff 
meeting attendance 
90% 
Balancing   
The incident rate of 
inappropriate referrals to 
inpatient SW and psychiatry 
MD 
Health Connect <10% increase from 
baseline 
Team 
Project Lead KS 
MD and CNM Leads KN & LW-N 
 
Social Work Lead MD 
RN Champions JK, TG, KW, DF-G & SC  
Director of Women’s and Children’s MB 
MD Consultants Dr. M, Dr. B, Dr. F 
Maternity Services Clinical Nurse Leader HC 
Quality Nurse Consultant RP 
 
Measurement Strategy 
Background (Global Aim): To decrease symptoms of perinatal mood disorders and increase 
women’s mental health, thus decreasing potential adverse effects on newborn babies and 
families. 
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Population Criteria: Inpatient perinatal patients who screen mild, moderate, or high on the C-
SSRS when admitted to the hospital. 
Data Collection Method: Data will be obtained daily from the hospital obstetrical census in 
Health Connect and a report generated from the regional database. 
Data Definitions 
Data Element Definition 
PHQ-9 Patient Health Questionnaire is the depression module of the DSM-
IV (American Psychiatric Association for the classification of 
mental disorders). 
C-SSRS Columbia-Suicide Severity Rating Scale. Suicide risk: low risk 
(score 1-2, no immediate concern or intervention required), 
moderate risk (score 3, intervention needed), or high risk (score 4-
6, intervention required). 
RN training Education for all labor and delivery and postpartum nurses on the 
C-SSRS workflow. 




Measure Measure Definition Data Collection Source Goal 
Percent of social 
work (SW) referrals 
for positive C-SSRS 
screening 
N = # of patients with 
SW referral (positive on 
C-SSRS) 
D = # of patients who 
screened positive on C-
SSRS  
Health Connect 90% 
Percent of psychiatry 
referrals for moderate 
or high C-SSRS 
screening 
N = # of psychiatry 
referrals 
D = # of moderate and 
high C-SSRS patients 
Health Connect 90% 
Percent of RNs 
trained on C-SSRS 
workflow 
N = # of postpartum 
(PP) nurses trained on 
the C-SSRS workflow  
D = # of total PP nurses  
Huddle and staff meeting 
attendance (sign off sheet) 
90% 
Key: N = numerator, D = denominator  
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Driver Diagram 
 Aim         Primary Driver            Secondary Driver    Change Ideas 
  
Increase utilization 
of the new C-
SSRS workflow 
from 0% to 90% 
by the end of July 
2021
% of patients referred 








Education and training 
of all L&D and PP RN's 
on C-SSRS workflow
Mandatory Education
RN's initiate SW 
referrals and follow C-
SSRS workflow
RN's educate the 




Changes to test 
1.  When patients screen low, moderate, or high on C-SSRS have established workflow. 
 
2.  When patients are admitted with a prenatal diagnosis of a PMAD, have an established 
workflow. 
3. When a baby goes to the NICU, have an established workflow. 
4. MB RN helps patients download the Calm app for all at-risk patients. 
5. Give all patients the Mind-Body-Spirit flyer before discharge. 
6. Use a team engagement plan with a kickoff for morale and motivation. 
  
Admitted postpartum patient
L&D RN conducts C-SSRS and 
puts in a SW referal for 
patients who score low, 
moderate, or high 
C-SSRS workflow initiated
L&D RN, Provider, or MB RN 
put in referal to SW for every 
patient with a prenatal 
diagnosis of a PMAD
PMAD workflow initiated  
(yet to be established)
L&D RN or MB RN put in SW 
referal for every parent who's 
baby gets admitted to the 
NICU
PMAD workflow initiated  





2/2021 3/2021 4/2021 5/2021 6/2021 7/2021 Ongoing 
Define the 
project 
       
Develop the 
AIM 
       
Review 
literature 
       
Microsystem 
assessment 
       
Develop 
charter 










       
Identify 
changes to test 
       
Driver diagram        
Complete 
charter 
       
Test changes        
Train staff on 
workflows 










Clinical Nurse Leaders (CNLs) are “positioned in the microsystem and serve as leaders 
of teams who often identify process or system concerns and then work with interdisciplinary 
colleagues to implement evidence-based interventions to achieve improvement” (Harris et al., 
2018, p. 313). While working in their microsystem, they embody several of the CNL 
competencies enacted by the American Association of Colleges of Nursing (AACN, 2007) in 
their white paper. 
Many competencies will be leveraged to implement a pathway for intervention and 
resources for at-risk inpatient perinatal women. The CNL will act as an educator and team 
leader, helping to coordinate and collaborate with the entire microsystem. The CNL works as an 
outcomes manager by looking at the processes to drive ideal results (King et al., 2019). As a 
systems analyst, the CNL is positioned to utilize and evaluate quality measures in their 
microsystem (King et al., 2019). With this scope of practice, the CNL will make evidence-based 





Appendix I. Statement of Non-Research Determination 
 
CNL Project: Statement of Non-Research Determination Form 
 
Student Name:___Kristin Schoen___________                                                                                                                
Title of Project:  
Columbia-Suicide Severity Rating Scale (C-SSRS) Inpatient Perinatal Clinical Pathway  
Brief Description of Project:  
Creating a clinical pathway for patients who screen positive (low, moderate, high risk) on 
the C-SSRS. Pathway will include using the validated screening tool to identify ‘at-risk’ 
postpartum patients. Using Health Connect we will audit all perinatal patients charts to 
ensure that all positive patients have a Social Work referral and are seen before 
discharge.  The obstetric provider will contact inpatient Psych MD when needed (for 
moderate and high risk patients), and work with the primary RN to make sure the patient 
gets resources handout prior to discharge. 
A) Aim Statement:  
To use established mental health screening to identify suicidal postpartum patients 
and develop an inpatient clinical pathway that includes interventions and resources 
to be shared with 90% of these patients by July of 2021.   
  
 
B) Description of Intervention:  
Create an easy-to-use pathway for nurses and providers when postpartum patients 
screen positive on the C-SSRS.  Have interventions and resources available for the 
patients. 
C) How will this intervention change practice?  
Earlier and consistent detection of at-risk, or suicidal, patients provides additional 
support and treatment.  Up to date list of resources available for all postpartum 
patients, consistently given to those who screen positive. 
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D) Outcome measurements:  
All patients that screen positive on the C-SSRS will be put on the C-SSRS 
pathway. 
Social Work referrals will be entered into HealthConnect (by the primary nurse) 
when patients screen positive on the C-SSRS pathway.   
Social Work and the Obstetrical provider determine which patients the inpatient 
Psych MD needs to see (based off of guidelines to be determined).  
All positive C-SSRS patients receive resource handout before discharge. 
To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the 
criteria outlined in federal guidelines will be used:  
(http://answers.hhs.gov/ohrp/categories/1569)  
☐   This project meets the guidelines for an Evidence-based Change in Practice Project as 
outlined in the Project Checklist (attached). Student may proceed with implementation. 
☐This project involves research with human subjects and must be submitted for IRB approval 
before project activity can commence. 
Comments:   
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST * 
 
Instructions: Answer YES or NO to each of the following statements: 
Project Title:  Columbia-Suicide Severity Rating Scale (C-SSRS) Inpatient 
Perinatal Clinical Pathway   
YES NO 
The aim of the project is to improve the process or delivery of care with 
established/ accepted standards, or to implement evidence-based change. There is 
no intention of using the data for research purposes. 
X  
The specific aim is to improve performance on a specific service or program and is 
a part of usual care.  ALL participants will receive standard of care. 
X  
The project is NOT designed to follow a research design, e.g., hypothesis testing 
or group comparison, randomization, control groups, prospective comparison 
groups, cross-sectional, case control). The project does NOT follow a protocol that 
overrides clinical decision-making. 
X  
The project involves implementation of established and tested quality standards 
and/or systematic monitoring, assessment or evaluation of the organization to 
ensure that existing quality standards are being met. The project does NOT 
develop paradigms or untested methods or new untested standards. 
X  
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The project involves implementation of care practices and interventions that are 
consensus-based or evidence-based. The project does NOT seek to test an 
intervention that is beyond current science and experience. 
X  
The project is conducted by staff where the project will take place and involves 
staff who are working at an agency that has an agreement with USF SONHP. 
X  
The project has NO funding from federal agencies or research-focused 
organizations and is not receiving funding for implementation research. 
X  
The agency or clinical practice unit agrees that this is a project that will be 
implemented to improve the process or delivery of care, i.e., not a personal 
research project that is dependent upon the voluntary participation of colleagues, 
students and/ or patients. 
X  
If there is an intent to, or possibility of publishing your work, you and supervising 
faculty and the agency oversight committee are comfortable with the following 
statement in your methods section:  “This project was undertaken as an Evidence-
based change of practice project at X hospital or agency and as such was not 
formally supervised by the Institutional Review Board.”  
X  
 
ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an 
Evidence-based activity that does NOT meet the definition of research.  IRB review is not 
required.  Keep a copy of this checklist in your files.  If the answer to ANY of these questions 
is NO, you must submit for IRB approval. 
 
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human 




STUDENT NAME (Please print):  
_____________________________Kristin Schoen______________ 
Signature of Student: 
______________________________________________________DATE__4/7/2021___      
 
SUPERVISING FACULTY MEMBER NAME (Please print):  
________________________________________________________________________ 
Signature of Supervising Faculty Member 
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